NCT02903914 Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02903875 Therapeutic Education Program for Laryngectomised Patients and Their Close Relations Status UNKNOWN Phase N/A
NCT02900963 Nutritional Status Assessment in Head and Neck Cancer Patients Receiving Radiotherapy or Chemo-radiotherapy Status COMPLETED Phase NA
NCT02897375 Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02892786 Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase NA
NCT02879968 Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer Status COMPLETED Phase N/A
NCT02841748 A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study Status COMPLETED Phase PHASE2
NCT02823574 Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT02794675 Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02792322 Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck Status COMPLETED Phase NA
NCT02789267 Nutrition and Quality of Life of Patients With Head and Neck Carcinoma After Radiotherapy Status TERMINATED Phase NA
NCT02776163 Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas Status COMPLETED Phase PHASE2
NCT02760667 Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT02759575 A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02741570 Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE3
NCT02724488 Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies Status COMPLETED Phase N/A
NCT02705833 Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada Status COMPLETED Phase N/A